Down Syndrome and Effects of Foot Muscle Exercise

February 12, 2022 updated by: Nazia Adeeb, Ziauddin University

Effects of Foot Muscle Exercise on Gross Motor Function and Balance Among Pes Planus Down Syndrome Patients

Down syndrome (DS) is a common chromosomal pediatric disorder and accounts for approximately 8 % of all congenital anomalies. Children with DS experience delays in Cognitive, Physical, Speech and Language development. Hypotonity and laxity that is part of its features causes delay on motor acquisition. Furthermore it causes musculoskeletal issues and lower extremity malalignment resulting in inefficient and abnormal pattern of movement compromising locomotion and day to day functions therefore, problems for the population further aggravates. Combined effects of these factors causes a high level of stress on foot as it provides the foundation for whole body therefore, individuals with Down syndrome are at risk for foot alignment problems. Pes planus being the most common amongst them and accounts for 91% of the total DS patients diagnosed. Pes planus causes alteration in foot kinetics and kinematics that not only interferes significantly with normal daily life activities as balance and gait but also increases the risk of musculoskeletal injuries. Hence researchers have shown interest in addressing this condition for the effective management of DS population. Conventional treatment approach are the use of insoles, foot orthosis and arch taping however, they fail to produce residual effect. Hence the present study is to determine the role of foot muscles exercises in Down Syndrome having pes planus since its effects are positively recorded in normal population.

Study Overview

Study Type

Interventional

Enrollment (Actual)

47

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sindh
      • Karachi, Sindh, Pakistan, 75530
        • ACELP (Institute of Child Development)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 15 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • • Clinically diagnosed cases of DS including both male and female.

    • Bilateral flexible pes planus on the basis of Navicular Drop Test.
    • Able to follow instructions and adhere to the exercise program.
    • Ambulating independently.

Exclusion Criteria:

  • • Visual or auditory impairment.

    • Lower limb trauma or surgical intervention past six months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Foot Muscle Exercise
Foot Muscle Exercise was given for 3 days per week for 40 minutes for the period of 6 months including home program
Active Comparator: Arch Support Insole and One Leg Balance Activities
Arch Support Insoles were provided that the child had to wear for 5 hours per day thrice weekly for 6 months plus performed one leg balance activities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gross Motor Function
Time Frame: Baseline
Gross Motor Function was assessed using GMFM-88 Dimensions D and E
Baseline
Gross Motor Function
Time Frame: 12 weeks
Gross Motor Function was assessed using GMFM-88 Dimensions D and E
12 weeks
Gross Motor Function
Time Frame: 24 weeks
Gross Motor Function was assessed using GMFM-88 Dimensions D and E
24 weeks
Balance
Time Frame: Baseline
Balance was assessed using Pediatric Balance Scale
Baseline
Balance
Time Frame: 12 weeks
Balance was assessed using Pediatric Balance Scale
12 weeks
Balance
Time Frame: 24 weeks
Balance was assessed using Pediatric Balance Scale
24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 22, 2021

Primary Completion (Actual)

October 31, 2021

Study Completion (Actual)

November 30, 2021

Study Registration Dates

First Submitted

February 12, 2022

First Submitted That Met QC Criteria

February 12, 2022

First Posted (Actual)

February 23, 2022

Study Record Updates

Last Update Posted (Actual)

February 23, 2022

Last Update Submitted That Met QC Criteria

February 12, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pes Planus Down Syndrome Patients

Clinical Trials on Foot Muscle Exercise Protocol

3
Subscribe